Ten-year locoregional recurrence risks in women with nodal micrometastatic breast cancer staged with axillary dissection

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 5, 2011, Pages

  Lupe, Krystine ^a   Truong, Pauline T ^a,b   Alexander, Cheryl ^a   Speers, Caroline ^a   Tyldesley, Scott ^a,b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Breast cancer; Locoregional recurrence; Nodal micrometastasis; Radiotherapy

Indexed keywords

BREAST CANCER; BREAST CONSERVING SURGERY; BREAST RADIOTHERAPY; CHEST WALL; HAZARD RATIO; KAPLAN-MEIER; LOCAL RECURRENCE; LOCOREGIONAL RECURRENCE; LYMPHOVASCULAR INVASIONS; MULTI VARIATE ANALYSIS; NODAL MICROMETASTASIS; NODE-NEGATIVE; NODE-POSITIVE;

MULTIVARIANT ANALYSIS; RADIOTHERAPY; SURGERY;

DISEASES;

COBALT 60; ESTROGEN RECEPTOR;

ARTICLE; AXILLARY LYMPH NODE; BREAST METASTASIS; CANCER INVASION; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; COHORT ANALYSIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LOCOREGIONAL RECURRENCE; LYMPH VESSEL; MAJOR CLINICAL STUDY; MICROMETASTASIS; PARTIAL MASTECTOMY; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AXILLA; BREAST; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM MICROMETASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RISK ASSESSMENT; TIME FACTORS;

EID: 81855225315     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.12.020     Document Type: Article

References (34)

1. B. Fisher, M. Bauer, and D.L. Wickerham Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: An NSABP update Cancer 52 1983 1551 1557 (Pubitemid 13018271)
2. A.E. Giuliano, P.S. Dale, and R.R. Turner Improved axillary staging of breast cancer with sentinel lymphadenectomy Ann Surg 222 1995 394 399
3. D.P. Cronin-Fenton, L.A. Ries, and L.X. Clegg Rising incidence rates of breast carcinoma with micrometastatic lymph node involvement J Natl Cancer Inst 99 2007 1044 1049 (Pubitemid 47232605)
4. M. van der Heiden-van der Loo, P.D. Bezemer, and A. Hennipman Introduction of sentinel node biopsy and stage migration of breast cancer Eur J Surg Oncol 32 2006 710 714 (Pubitemid 44276004)
5. American Joint Committee on Cancer Breast AJCC cancer staging manual 5th ed 1997 Lippincott-Raven Philadelphia
6. F.L. Greene, D.L. Page, and I.D. Fleming AJCC cancer staging handbook. TNM classification of malignant tumors 6th ed 2002 Springer Verlag New York
7. G.P. Kuijt, A.C. Voogd, and L.V. van de Poll-Franse The prognostic significance of axillary lymph-node micrometastases in breast cancer patients Eur J Surg Oncol 31 2005 500 505 (Pubitemid 40724091)
8. P.T. Truong, V. Vinh-Hung, G. Cserni for the Member of the International Nodal Ratio Working Group The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer Eur J Cancer 44 2008 1670 1677
9. S.L. Chen, F.M. Hoehne, and A.E. Giuliano The prognostic significance of micrometastases in breast cancer: A SEER population-based analysis Ann Surg Oncol 4 2007 3378 3784
10. D. Grabau, M.B. Jensen, and F. Rank Axillary lymph node micrometastases in invasive breast cancer: National figures on incidence and overall survival APMIS 115 2007 828 837 (Pubitemid 47030098)
11. Y. Umekita, Y. Ohi, and Y. Sagara Clinical significance of occult micrometastases in axillary lymph nodes in "node-negative" breast cancer patients Jpn J Cancer Res 93 2002 695 698 (Pubitemid 34846277)
12. W. Reed, P.J. Bøhler, and B. Sandstad Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up Breast J 10 2004 174 180 (Pubitemid 38715730)
13. C.E. Cox, J.V. Kiluk, and A.I. Riker Significance of sentinel lymph node micrometastases in human breast cancer J Am Coll Surg 206 2008 261 268
14. L.K. Tan, D. Giri, and A.J. Hummer Occult axillary node metastases in breast cancer are prognostically significant: Results in 368 node-negative patients with 20-year follow-up J Clin Oncol 26 2008 1803 1809
15. M. de Boer, C.H. van Deurzen, and J.A. van Dijck Micrometastases or isolated tumor cells and the outcome of breast cancer N Engl J Med 361 2009 653 663
16. M. de Boer, J.A. van Dijck, and P. Bult Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases J Natl Cancer Inst 102 2010 410 425
17. N. Wasif, X. Ye, and A.E. Giuliano Survey of ASCO members on management of sentinel node micrometastases in breast cancer: Variation in treatment recommendations according to specialty Ann Surg Oncol 16 2009 2442 2449
18. M. Colleoni, N. Rotmensz, and G. Peruzzotti Size of breast cancer metastases in axillary lymph nodes: Clinical relevance of minimal lymph node involvement J Clin Oncol 23 2005 1379 1389
19. I. Langer, U. Guller, and C.T. Viehl Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: Long-term outcomes of a prospective study Ann Surg Oncol 16 2009 3366 3374
20. C.S. Bulte, M. van der Heiden-van der Loo, and A. Hennipman Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study Eur J Surg Oncol 35 2009 25 31
21. S. Pernas, M. Gil, A. Benítez, and M.T. Bajen Avoiding axillary treatment in sentinel lymph node micrometastases of breast cancer: A prospective analysis of axillary or distant recurrence Ann Surg Onco l 17 2010 772 777
22. K.Y. Bilimoria, D.J. Bentrem, and N.M. Hansen Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer J Clin Oncol 27 2009 2946 2953
23. J. Reed, M. Rosman, and K.M. Verbanac Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-Year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study J Am Coll Surg 208 2009 333 340
24. G.H. Lyman, A.E. Giuliano, and M.R. Somerfield American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer J Clin Oncol 23 2005 7703 7720 (Pubitemid 46291835)
25. U. Veronesi, G. Paganelli, and G. Viale A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer N Engl J Med 349 2003 546 553 (Pubitemid 36951366)
26. G. Cserni, D. Gregori, and F. Merletti Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer Br J Surg 91 2004 1245 1252 (Pubitemid 39331448)
27. D.M. Van Deurzen, M. de Boer, and E.M. Monninkhof Non sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node J Natl Cancer Inst 100 2008 1574 1580
28. N. Wasif, M.A. Maggard, and C.Y. Ko Underuse of axillary dissection for the management of sentinel node micrometastases in breast cancer Arch Surg 145 2010 161 166
29. A. Giuliano, L. McCall, and P. Beitsch Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: The American College of Surgeons Oncology Group Z0011 randomized trial Ann Surg 252 2010 426 433
30. M. Clarke, R. Collins, S. Darby for the Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials Lancet 366 2005 2087 2106 (Pubitemid 41797643)
31. M. Overgaard, H.M. Nielsen, and J. Overgaard Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 B&C randomized trials Radiother Oncol 82 2007 247 253 (Pubitemid 46350797)
32. J. Ragaz, I.A. Olivotto, and J.J. Spinelli Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-Year results of the British Columbia randomized trial J Natl Cancer Inst 97 2005 116 126 (Pubitemid 40277091)
33. National Cancer Institute, Clinical Trials. Available from: http://www.cancer.gov/clinicaltrials/CAN-NCIC-MA20. Accessed June 25, 2010.
34. SUPREMO, an MRC phase III randomized trial to assess the risk of adjuvant chest wall irradiation in "intermediate risk" operable breast cancer following mastectomy. Available from http://www.supremo-trial.com/pdfs/ SUPREMO20protocol20version2220final220july2005.pdf. Accessed June 25, 2010